Innoviva, Inc. (INVA)
23.06
+0.07
(+0.30%)
USD |
NASDAQ |
May 01, 12:05
Innoviva Price : 23.06 for May 1, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cytokinetics, Inc. | 65.23 |
| Merck & Co., Inc. | 112.90 |
| Regeneron Pharmaceuticals, Inc. | 705.39 |
| Ironwood Pharmaceuticals, Inc. | 4.35 |
| Artiva Biotherapeutics, Inc. | 10.49 |
Price Related Metrics
| PE Ratio | 7.548 |
| PS Ratio | 4.304 |
| PEG Ratio | 0.0055 |
| Price to Book Value | 1.456 |
| Price to Free Cash Flow | 9.345 |
| Earnings Yield | 13.25% |
| Market Cap | 1.708B |
| PEGY Ratio | 0.0055 |
| Operating PE Ratio | 11.17 |
| Normalized PE Ratio | 11.78 |